Al-Mousa Hamoud, Al-Saud Bandar
Department of Pediatrics, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Department of Genetics, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Front Immunol. 2017 Jun 26;8:678. doi: 10.3389/fimmu.2017.00678. eCollection 2017.
Middle East and North Africa region (MENA) populations are of different ethnic origins. Consanguineous marriages are common practice with an overall incidence ranging between 20 and 50%. Primary immunodeficiency diseases (PIDs) are a group of heterogeneous genetic disorders caused by defects in the immune system that predisposes patients to recurrent infections, autoimmune diseases, and malignancies. PIDs are more common in areas with high rates of consanguineous marriage since most have an autosomal recessive mode of inheritance. Studies of PIDs in the region had contributed into the discovery and the understanding of several novel immunodeficiency disorders. Few MENA countries have established national registries that helped in estimating the prevalence and defining common PID phenotypes. Available reports from those registries suggest a predominance of combined immunodeficiency disorders in comparison to antibody deficiencies seen in other populations. Access to a comprehensive clinical immunology management services is limited in most MENA countries. Few countries had established advanced clinical immunology service, capable to provide extensive genetic testing and stem cell transplantation for various immunodeficiency disorders. Newborn screening for PIDs is an essential need in this population considering the high incidence of illness and can be implemented and incorporated into existing newborn screening programs in some MENA countries. Increased awareness, subspecialty training in clinical immunology, and establishing collaborating research centers are necessary to improve patient care. In this review, we highlight some of the available epidemiological data, challenges in establishing diagnosis, and available therapy for PID patients in the region.
中东和北非地区(MENA)的人群有着不同的种族起源。近亲结婚很常见,总体发生率在20%至50%之间。原发性免疫缺陷病(PID)是一组由免疫系统缺陷引起的异质性遗传疾病,使患者易患反复感染、自身免疫性疾病和恶性肿瘤。由于大多数PID具有常染色体隐性遗传模式,因此在近亲结婚率高的地区更为常见。该地区对PID的研究有助于发现和理解几种新型免疫缺陷疾病。中东和北非地区很少有国家建立了全国性登记系统,这有助于估计发病率并确定常见的PID表型。这些登记系统提供的报告表明,与其他人群中常见的抗体缺陷相比,联合免疫缺陷疾病更为普遍。在大多数中东和北非国家,获得全面的临床免疫学管理服务的机会有限。很少有国家建立了先进的临床免疫学服务机构,能够为各种免疫缺陷疾病提供广泛的基因检测和干细胞移植。考虑到该人群中疾病的高发病率,对PID进行新生儿筛查是一项基本需求,并且在一些中东和北非国家可以实施并纳入现有的新生儿筛查项目。提高认识、开展临床免疫学专科培训以及建立合作研究中心对于改善患者护理至关重要。在本综述中,我们重点介绍了该地区一些现有的流行病学数据、确立诊断的挑战以及PID患者可用的治疗方法。